Sedative-hypnotic use of diphenhydramme in a rural, older adult, community-based cohort

Effects on cognition

Ranita Basu, Hiroko Dodge, Gary P. Stoehr, Mary Ganguli

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: The authors sought to identify patterns and associations of prescription and over-the-counter sedative-hypnotic use in an older, rural, blue-collar, community-based cohort in southwestern Pennsylvania over 10 years. Methods: A group of 1, 627 individuals age 65 and over were recruited and assessed during 1987-1989 and reassessed during approximately biennial waves. Data included sleep medications, demographics, depressive symptoms, sleep complaints, and cognitive functioning (Mini-Mental State Exam [MMSE]). Results: At Waves 1 through 5, the mean age of the cohort increased from 73.4 to 80.5 years. Use of prescription sedative-hypnotics (primarily benzodiazepines) increased from 1.8% to 3.1%, and over-the-counter sedative-hypnotic use (primarily diphenhydramine) increased from 0.4% to 7.6%. At Wave 5 (1996-1998), 8.17% of the sample reported using diphenhydramine as a sleep aid. After adjusting for age and sex, diphenhydramine use was associated with higher education and more depressive symptoms, the latter becoming nonsignificant after controlling for initial insomnia. MMSE became significantly associated with diphenbydramine use when 143 subjects with dementia were excluded from the analysis. Conclusion: As the cohort aged, prescription sedative-hypnotic use remained relatively stable, whereas over-the-counter sedative use, principally diphenhydramine, increased substantially The association of this drug with cognitive impairment in persons without dementia highlights its potential for causing adverse reactions in older adults.

Original languageEnglish (US)
Pages (from-to)205-213
Number of pages9
JournalAmerican Journal of Geriatric Psychiatry
Volume11
Issue number2
DOIs
StatePublished - 2003
Externally publishedYes

Fingerprint

Cohort Effect
Diphenhydramine
Hypnotics and Sedatives
Cognition
Prescriptions
Sleep
Dementia
Depression
Sleep Initiation and Maintenance Disorders
Benzodiazepines
Demography
Education
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Sedative-hypnotic use of diphenhydramme in a rural, older adult, community-based cohort : Effects on cognition. / Basu, Ranita; Dodge, Hiroko; Stoehr, Gary P.; Ganguli, Mary.

In: American Journal of Geriatric Psychiatry, Vol. 11, No. 2, 2003, p. 205-213.

Research output: Contribution to journalArticle

@article{e5c491eac48b4885a58f892d4f7363d6,
title = "Sedative-hypnotic use of diphenhydramme in a rural, older adult, community-based cohort: Effects on cognition",
abstract = "Objective: The authors sought to identify patterns and associations of prescription and over-the-counter sedative-hypnotic use in an older, rural, blue-collar, community-based cohort in southwestern Pennsylvania over 10 years. Methods: A group of 1, 627 individuals age 65 and over were recruited and assessed during 1987-1989 and reassessed during approximately biennial waves. Data included sleep medications, demographics, depressive symptoms, sleep complaints, and cognitive functioning (Mini-Mental State Exam [MMSE]). Results: At Waves 1 through 5, the mean age of the cohort increased from 73.4 to 80.5 years. Use of prescription sedative-hypnotics (primarily benzodiazepines) increased from 1.8{\%} to 3.1{\%}, and over-the-counter sedative-hypnotic use (primarily diphenhydramine) increased from 0.4{\%} to 7.6{\%}. At Wave 5 (1996-1998), 8.17{\%} of the sample reported using diphenhydramine as a sleep aid. After adjusting for age and sex, diphenhydramine use was associated with higher education and more depressive symptoms, the latter becoming nonsignificant after controlling for initial insomnia. MMSE became significantly associated with diphenbydramine use when 143 subjects with dementia were excluded from the analysis. Conclusion: As the cohort aged, prescription sedative-hypnotic use remained relatively stable, whereas over-the-counter sedative use, principally diphenhydramine, increased substantially The association of this drug with cognitive impairment in persons without dementia highlights its potential for causing adverse reactions in older adults.",
author = "Ranita Basu and Hiroko Dodge and Stoehr, {Gary P.} and Mary Ganguli",
year = "2003",
doi = "10.1097/00019442-200303000-00011",
language = "English (US)",
volume = "11",
pages = "205--213",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Sedative-hypnotic use of diphenhydramme in a rural, older adult, community-based cohort

T2 - Effects on cognition

AU - Basu, Ranita

AU - Dodge, Hiroko

AU - Stoehr, Gary P.

AU - Ganguli, Mary

PY - 2003

Y1 - 2003

N2 - Objective: The authors sought to identify patterns and associations of prescription and over-the-counter sedative-hypnotic use in an older, rural, blue-collar, community-based cohort in southwestern Pennsylvania over 10 years. Methods: A group of 1, 627 individuals age 65 and over were recruited and assessed during 1987-1989 and reassessed during approximately biennial waves. Data included sleep medications, demographics, depressive symptoms, sleep complaints, and cognitive functioning (Mini-Mental State Exam [MMSE]). Results: At Waves 1 through 5, the mean age of the cohort increased from 73.4 to 80.5 years. Use of prescription sedative-hypnotics (primarily benzodiazepines) increased from 1.8% to 3.1%, and over-the-counter sedative-hypnotic use (primarily diphenhydramine) increased from 0.4% to 7.6%. At Wave 5 (1996-1998), 8.17% of the sample reported using diphenhydramine as a sleep aid. After adjusting for age and sex, diphenhydramine use was associated with higher education and more depressive symptoms, the latter becoming nonsignificant after controlling for initial insomnia. MMSE became significantly associated with diphenbydramine use when 143 subjects with dementia were excluded from the analysis. Conclusion: As the cohort aged, prescription sedative-hypnotic use remained relatively stable, whereas over-the-counter sedative use, principally diphenhydramine, increased substantially The association of this drug with cognitive impairment in persons without dementia highlights its potential for causing adverse reactions in older adults.

AB - Objective: The authors sought to identify patterns and associations of prescription and over-the-counter sedative-hypnotic use in an older, rural, blue-collar, community-based cohort in southwestern Pennsylvania over 10 years. Methods: A group of 1, 627 individuals age 65 and over were recruited and assessed during 1987-1989 and reassessed during approximately biennial waves. Data included sleep medications, demographics, depressive symptoms, sleep complaints, and cognitive functioning (Mini-Mental State Exam [MMSE]). Results: At Waves 1 through 5, the mean age of the cohort increased from 73.4 to 80.5 years. Use of prescription sedative-hypnotics (primarily benzodiazepines) increased from 1.8% to 3.1%, and over-the-counter sedative-hypnotic use (primarily diphenhydramine) increased from 0.4% to 7.6%. At Wave 5 (1996-1998), 8.17% of the sample reported using diphenhydramine as a sleep aid. After adjusting for age and sex, diphenhydramine use was associated with higher education and more depressive symptoms, the latter becoming nonsignificant after controlling for initial insomnia. MMSE became significantly associated with diphenbydramine use when 143 subjects with dementia were excluded from the analysis. Conclusion: As the cohort aged, prescription sedative-hypnotic use remained relatively stable, whereas over-the-counter sedative use, principally diphenhydramine, increased substantially The association of this drug with cognitive impairment in persons without dementia highlights its potential for causing adverse reactions in older adults.

UR - http://www.scopus.com/inward/record.url?scp=0037371171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037371171&partnerID=8YFLogxK

U2 - 10.1097/00019442-200303000-00011

DO - 10.1097/00019442-200303000-00011

M3 - Article

VL - 11

SP - 205

EP - 213

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 2

ER -